Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Kidney Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06519760
What this trial is testing

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

Who this might be right for
Carbonic Anhydrase IXPET-CTClear Cell Renal Cell Carcinoma
Peking University First Hospital 200
Early research (Phase 1)Study completedNCT00199888
What this trial is testing

Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.

Who this might be right for
Cancer of KidneyKidney CancerRenal Cancer+4 more
Ludwig Institute for Cancer Research 26
Early research (Phase 1)Not Yet RecruitingNCT06870279
What this trial is testing

A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
RenJi Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06866262
What this trial is testing

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Who this might be right for
Locally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more
University of Michigan Rogel Cancer Center 55
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Not applicableStudy completedNCT02247583
What this trial is testing

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

Who this might be right for
Clear Cell Renal Cell Carcinoma
KU Leuven 90
Not applicableStudy completedNCT06559046
What this trial is testing

A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study

Who this might be right for
Tumor GradingDeep LearningClear Cell Renal Cell Carcinoma
Ting Huang 483
Testing effectiveness (Phase 2)Active Not RecruitingNCT05363631
What this trial is testing

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Who this might be right for
Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
Mohammed Milhem 55
Testing effectiveness (Phase 2)Ended earlyNCT02923531
What this trial is testing

Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
X4 Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT01896271
What this trial is testing

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 30
Early research (Phase 1)Study completedNCT04169711
What this trial is testing

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Arrowhead Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT01767636
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Carcinoma of the Collecting Ducts of BelliniChromophobe Renal Cell CarcinomaKidney Medullary Carcinoma+6 more
Mayo Clinic 38
Large-scale testing (Phase 3)Study completedNCT00326898
What this trial is testing

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7Stage II Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 1,943
Testing effectiveness (Phase 2)Study completedNCT01263769
What this trial is testing

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01392183
What this trial is testing

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Ended earlyNCT00496756
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska 14
Early research (Phase 1)Looking for participantsNCT06942104
What this trial is testing

Imaging of Solid Tumors Using 18F-TRX

Who this might be right for
Solid TumorSolid CarcinomaCastration-Resistant Prostate Carcinoma+7 more
Rahul Aggarwal 56
Testing effectiveness (Phase 2)UnknownNCT02880943
What this trial is testing

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaBone Metastases
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 42
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Next Page